61
|
|
|
Poly(A) binding protein interacting protein 2B |
- |
|
62
|
|
|
P21 (RAC1) activated kinase 1 |
IDDMSSD, PAKalpha, alpha-PAK, p65-PAK |
|
63
|
|
|
P21 (RAC1) activated kinase 2 |
KNO2, PAK65, PAKgamma |
|
64
|
|
|
P21 (RAC1) activated kinase 3 |
ARA, MRX30, MRX47, OPHN3, PAK-3, PAK3beta, XLID30, bPAK, beta-PAK |
|
65
|
|
|
P21 (RAC1) activated kinase 4 |
- |
|
66
|
|
|
P21 (RAC1) activated kinase 5 |
PAK7 |
|
67
|
|
|
P21 (RAC1) activated kinase 6 |
PAK5 |
|
68
|
|
|
Partner and localizer of BRCA2 |
BROVCA5, FANCN, PNCA3 |
Attention deficit hyperactivity disorder, Autism, Biliary tract cancer, Bipolar disorder, Breast cancer, Breast neoplasms, Hereditary breast-ovarian cancer syndrome, Cancer, Cervical cancer, Chordoma, Colorectal cancer, Lynch syndrome, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Pancreatic cancer, Fanconi anemia, Gastric cancer, Hepatocellular carcinoma, Hereditary breast and ovarian cancer syndrome, Hereditary breast cancer, Lung cancer, Major depressive disorder, Non-hodgkins lymphoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic neoplasms, Prostate cancer, Prostatic neoplasms, Schizophrenia, Squamous cell carcinomaView all (16 more) |
69
|
|
|
Phosphatase domain containing paladin 1 |
KIAA1274, PALD |
|
70
|
|
|
Palladin, cytoskeletal associated protein |
CGI-151, CGI151, MYN, PNCA1, SIH002 |
Central nervous system cancer, Colorectal cancer, Coronary artery disease, Coronary thrombosis, Pancreatic cancer, Glioblastoma, Glioma, Lung cancer, Pancreatic neoplasms, Psoriasis, Scoliosis, Squamous cell carcinoma, Diabetes mellitus type 2 |